title: Intravenous thrombolysis for stroke after Dabigatran reversal with Idarucizumab: an update.
authors.affiliation: USD Stroke Unit, DAI di Neuroscienze, Azienda Ospedaliera Universitaria Integrata, Piazzale A. Stefani 1, 37126, Verona, Italy. manuel_cappellari@libero.it.
authors.forename: Manuel
authors.initials: M
authors.lastname: Cappellari
authors.affiliation: USD Stroke Unit, DAI di Neuroscienze, Azienda Ospedaliera Universitaria Integrata, Piazzale A. Stefani 1, 37126, Verona, Italy.
authors.forename: Stefano
authors.initials: S
authors.lastname: Forlivesi
authors.affiliation: USD Stroke Unit, DAI di Neuroscienze, Azienda Ospedaliera Universitaria Integrata, Piazzale A. Stefani 1, 37126, Verona, Italy.
authors.forename: Giovanna Maddalena
authors.initials: GM
authors.lastname: Squintani
authors.affiliation: Laboratorio Analisi, DAI Patologia e Diagnostica, Azienda Ospedaliera Universitaria Integrata, Verona, Italy.
authors.forename: Roberto
authors.initials: R
authors.lastname: Facchinetti
authors.affiliation: USD Stroke Unit, DAI di Neuroscienze, Azienda Ospedaliera Universitaria Integrata, Piazzale A. Stefani 1, 37126, Verona, Italy.
authors.forename: Paolo
authors.initials: P
authors.lastname: Bovi
mesh_terms: D061605:Administration, Intravenous; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D000069604:Dabigatran / Q000037:antagonists & inhibitors* / Q000627:therapeutic use; D006801:Humans; D020521:Stroke / Q000188:drug therapy*; D015912:Thrombolytic Therapy / Q000379:methods*
chemical_list: D061067:Antibodies, Monoclonal, Humanized; C000594745:idarucizumab; D000069604:Dabigatran